SASuheyla Aytaç Arslan

Suheyla Aytaç Arslan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Suheyla Aytaç Arslan has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pre-treatment MRI-derived fractal dimension as a prognostic marker in cervical cancer treated with definitive radiotherapy with or without concurrent chemotherapy

    by Sedef Gökhan Açıkgöz, Ayfer Bakır, Büşra Demir Çendek, Havva Beyaz, Süheyla Aytaç Arslan, Fevziye İlknur Kayalı, Rahşan Habiboğlu, Yılmaz Tezcan

    Pre-treatment magnetic resonance imaging (MRI) plays a central role in local staging and treatment planning for cervical cancer. Fractal dimension (FD) ana

  • Radiotherapy, Female Fertility and Ootoxicity

    by İpEk Pınar Aral, Havva Beyaz, Suheyla Aytaç Arslan, Sedef Gökhan Açikgöz, Yılmaz Tezcan

    Fertility is an important component of quality of life and oncological patients should be questioned about their expectations before treatment. Radiotherapy (RT) can adversely affect fertility irreversibly and progressively. Therefore, patients with expectation of fertility should be evaluated before RT and guided for appropriate interventions. Radiotherapy negatively affects fertility in many aspects. Cranial RT disrupts the hypothalamus-pituitary-ovarian (H-P-O) axis, pelvic RT directly affects the ovary and uterus. Because of the long latent period of endocrinopathies caused by cranial RT, these patients should be followed up for a long time. Due to dose-dependent uterine and ovarian toxicities that develop after abdominopelvic RT, patients are at high risk for infertility and pregnancy complications. Uterus and ovaries have different radiosensitivity depending on age. With aging, radiosensitivity of the uterus decreases, while radiosensitivity of the ovaries increase. Although there is no consensus on the threshold doses that can cause RT-related infertility, according to current data, the threshold value for the hypothalamo-pituitary axis is 30 Gy; 25 Gy for young women and 45 Gy for adult women for the uterus; 10 Gy for acute ovarian failure in the ovary and 25 Gy for premature ovarian failure under 35 years of age. There is no significant relationship between parental radiation exposure and inherited genetic disease in their infants.


  • Radiosensitizer-Releasing Fiducial ‘Nanofiducial’: A New Concept in Radiotherapy

    by I.P. Aral, G. Tezel, G.A. Inan, A.K. Aksakal, Z. Gani, S. Aytac Arslan, I. Eroğlu, O. Alp, H. Eroğlu, Y. Tezcan

  • Psoas Muscle Loss During Treatment is a Negative Predictive Factor in Gastric Cancer Patients

    by Hüseyin Furkan Öztürk, Süheyla Aytaç Arslan, Gonca Altınışık İnan, İpek Pınar Aral, Yılmaz Tezcan

    Adjuvant radiochemotherapy,concurrent radiochemotherapy,gastric cancer,nutrition therapy,sarcopenia

  • Open Access

    The association of anemia and high neutrophil-lymphocyte ratio with decreased survival in patients with laryngeal cancer treated with radiotherapy

    by Ela Deli̇kGöz Soykut, Yasemin Kemal, Serkan Kaplan, Cengiz Karaçi̇n, Eylem Odabaşi, Asude Unal, Zehra Er, Suheyla Aytaç Arslan, Yıldız Guney

    Aims: We aimed to examine the prognostic value of inflammatory markers such as neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and anemia on oncological outcomes in patients with laryngeal squamous cell carcinomas (LSCC) treated with radiotherapy. Methods: 213 LSCC patients analyzed retrospectively. Inflammatory markers were established by examining blood samples taken within 7 days before treatment. Patients were categorized into two groups: low and high according to NLR, PLR, and SII threshold values. In addition, to evaluate the effect of hemoglobin (Hb) level, the threshold value of each inflammatory marker and Hb level were combined, and 3 groups were formed (3 groups for NLR, 3 groups for PLR, and 3 groups for SII). The relationship between inflammatory markers and overall survival (OS), disease-free survival (DFS), and local regional recurrence-free survival (LRRFS) was investigated. Results: In univariate analysis, high NLR, PLR, SII, and low Hb (

  • Open Access

    Clinical outcomes of palliative 3-dimensional conformal external beam gastric radiotherapy: single center experience

    by Hüseyin Furkan Öztürk, Gonca Altinişik İnan, İpek Pınar Aral, Suheyla Aytaç Arslan, Sedef Gökhan Açikgöz, Havva Beyaz, Yılmaz Tezcan

    Aim: Patients diagnosed with locally advanced and/or metastatic gastric cancer and who cannot undergo surgery may need palliative treatment during their follow-up. There is scarce data about outcomes of palliative gastric radiotherapy (RT). In this study, we aimed to investigate the effect of 3-D external beam RT on oncological outcomes, as a non-invasive method. Material and Method: From 2013 to 2017, sixteen gastric cancer patients treated with palliative external RT in our institutional clinic were evaluated. Only patients who received palliative gastric radiotherapy for obstruction, pain and bleeding were analyzed, and patients who had previously received RT to the abdomen or who were given RT for adjuvant purposes were not included in the analysis. Results: Seven patients (43%) were not able to finish the planned palliative course. Thirty Gray with 10 fractions was the most planned RT schedule. Almost half of the patients (%56) received chemotherapy before RT. Overall survival was found to be median 2 months. Median survival was better in patients who were able to receive 28 Gy bioequivalent dose (4 vs 0.3 months, p≤0.00). Purpose of palliation also found to be a significant factor on survival. Patients who were referred for pain have found to be better survival rather than bleeding and obstruction (13 vs 0.7 months, p=0.03). Conclusion: External radiotherapy is an easily applicable and effective method for palliation in gastric cancer patients. Early referral for radiotherapy in patients who need palliation may increase oncological outcomes. It has been observed that the prognosis is worse in patients who received palliative radiotherapy due to gastric bleeding and obstruction.

  • Factors on development and severity of acute radiodermatitis: prospective single-center study

    by Gonca Altinişik İnan, Alaettin Arslan, İpek Pınar Aral, Suheyla Aytaç Arslan

    Aim: Although prior literature has examined the treatment and patient-associated factors affecting the development and severity of acute radiodermatitis, there are relatively few prospective studies evaluating both. This study was prospectively designed to evaluate factors affecting the development and extent of radiation-induced acute skin toxicity called radiodermatitis (RD). Material and Method: A total of 63 patients who underwent radiotherapy (RT) in Ankara Atatürk Research and Education Hospital between July 2017 and October 2018 were evaluated. Patients’ demographic status, disease/treatment details, hemoglobin, ferritin, folic acid, Vit B12, and hemoglobin A1c values were recorded. The development and grade of RD were evaluated weekly by the same radiation oncologist using the Radiation Therapy Oncology Group (RTOG) radiation toxicity guideline. Results: There was no significant relationship between the development of any degree of RD and gender, concomitant chemotherapy (CT), pre-RT CT, comorbid disease, RT technique and blood parameters (Hb, Hba1c, ferritin, folic acid and B12). The development of grade 2-3 RD was significantly affected by the number of operations (p=0.032) and total dose of RT (p=0.008). In patients with grade 2/3 RD, the RT dose at which RD first appeared was 20 Gy (range, 14-36); in patients with grade 1 RD, this value was 32 Gy (range, 16-56) (p=0.018). Conclusion: There is no significant relationship between the development of acute radiodermatitis and Hba1c, hemoglobin, ferritin, B12 and folic acid levels. There was a significant correlation between grade of RD and repeated surgery, increase in total RT dose and early onset of RD.


  • Adjuvant Radiotherapy for the Multimodal Treatment of Pediatric Ewing Sarcoma

    by Gonca Altinişik İnAn, İpEk Pınar Aral, Tarık KARGIOĞLU, Arzu Yazal Erdem, Selma Çakmakci, Hüseyin Furkan Öztürk, Suheyla Aytaç Arslan, Yılmaz Tezcan

    Aim: This study aimed to report the adjuvant radiotherapy results of pediatric patients with Ewing sarcoma who received multimodal treatment for this rare disease using modern radiotherapy (RT) techniques. Material and Methods: Pediatric patients with Ewing Sarcoma (ES) who received adjuvant radiotherapy were evaluated retrospectively. The study’s primary endpoint was overall survival (OS) and disease-free survival (DFS). The secondary endpoint was local relapse-free survival after RT (LRFS- RT) and overall survival after RT (OS-RT). Results: The results of 18 pediatric patients diagnosed with Ewing Sarcoma in our clinic between 09.12.2013-04.04.2021 and underwent RT for adjuvant were evaluated retrospectively. The three patients were excluded since they did not meet the inclusion criteria. The median age of the patients at the time of diagnosis was 10.5 (range 3-17). The time from diagnosis to the onset of RT was 8.6 (range 2-20) months. The median fraction dose was 180 cGy, and the median total RT dose was 50.4 (range 45-55.80) Gy. The median follow-up period of the study was 27 (range 11-86) months. The 12 (80%) patients survived, and 3 (20%) died. The median OS diagnosis of the patients was 27.3 (range 11 to 86.5) months. The overall survival of the patients after RT was median 17.3 (range 4.4-83.9) months. Recurrence (local+distant) was observed in 7 patients (46.7%); 2 (13.3%) local, 3 (20%) distant and 2 (13.3%) both. The median DFS was 24 months (range 1-86.5). Median LRFS-RT is 14.2 (range 1-83.9) months. The relationship between LRFS-RT and age (


  • Open Access

    Factors on Development and Severity of Acute Radiodermatitis: Prospective Single-Centre Study

    by Gonca Altınışık İnan, Alaettin Arslan, İpek Pınar Aral, Suheyla Aytaç Arslan

    Background: Although prior literature has examined the treatment and patient-associated factors affecting the development and severity of acute radiodermatitis, there are relatively few prospective studies evaluating both.Aims and Objectives: This study was prospectively designed to evaluate factors affecting the development and extent of radiation-induced acute skin toxicity called radiodermatitis (RD).Materials and Methods: A total of 63 patients who underwent radiotherapy (RT) in Ankara Atatürk Research and Education Hospital between 20.06.2016 and 21.10.2017 were evaluated. Patients' demographic status, disease/treatment details, anemia, and diabetic profile tests’ (hemoglobin, ferritin, folic acid, Vit B12, and hemoglobin A1c) were recorded. The development and the degree of RD were assessed weekly by treating radiation oncologists using Radiation Therapy Oncology Group (RTOG) radiation toxicity manual.Results: The development of any grade of RD was not significantly affected by gender, concurrent chemotherapy (CT), pre-RT CT, the comorbid disease, RT technic, and anemia & diabetic profile tests’ values. The development of grade 2-3 RD was significantly affected by the number of operations (p = 0.032) and total dose of RT (p = 0.008). The starting dose for RD is 20 Gy in patients with grade 2-3 RD and 32 Gy in patients with grade 1 RD (p = 0.018).Conclusion: There was no significant relationship between RD and anemia/diabetic profile parameters. The severity of RD was associated with recurrent surgical intervention, total dose, and early onset of RD.

  • Open Access

    Palliative treatment of Kaposi sarcoma with radiotherapy: a single center experience

    by Gonca Altinisik Inan, Ipek Pinar Aral, Suheyla Aytac Arslan, Yilmaz Tezcan

    The aim of this study is to evaluate the treatment responses of Kaposi sarcoma patients treated with radiotherapy (RT). The data of 18 patients (40 different regions) who were treated for Kaposi sarcoma in OOOO between March 23, 2010 to February 13, 2018 were evaluated retrospectively. The primary endpoint of the study was the clinical-subjective response after RT, and the secondary endpoint was the visual response assessment after RT. In evaluating the patients' reported response of the lesions: 25 (62.5%) of complete response (CR), 12 (30%) of partial response (PR), and stable response was seen in 3 patients (7.5%). Patient reported response after RT was significantly higher in male sex (p = 0.002; odds ratio [OR] = 13.8, 95% confidence interval [CI], 2.7-70.0). Physician reported response rates were available for 28 lesions and CR was detected in 12 lesions (30%); PR was observed in 16 (40%). The relationship between physician reported outcome and RT techniques (electron, bolus, or water bolus) is close to the limit of statically significance (p = 0.052). Fewer lesions disappeared in patients with photon preference than electrons (p = 0.036; OR = 0.093; 95% CI, 0.009-0.950). Patients' reported complete response rates were significantly higher in the 20 Gy per 5 fractions treatment arm (p = 0.042; OR = 1.75; 95% CI, 1.1-2.7). RT is an effective local treatment with high response rates in the treatment of Kaposi sarcoma. The subjective-clinical response rate was higher in male sex and the visual response was higher in the 20 Gy per 5 fractions arm. Additional studies are needed to standardize RT dose and techniques.